Kronox Lab Sciences Limited (BOM:544187)
India flag India · Delayed Price · Currency is INR
127.00
-2.55 (-1.97%)
At close: Feb 12, 2026

Kronox Lab Sciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
999.621,002898.62955.78822.47624.6
Other Revenue
-0---1.331.59
Revenue
999.621,002898.62955.78823.8626.19
Revenue Growth (YoY)
7.56%11.50%-5.98%16.02%31.56%23.29%
Cost of Revenue
496.55513.18462.54552.62477347.08
Gross Profit
503.07488.76436.09403.16346.8279.11
Selling, General & Admin
60.4347.5462.2970.2757.8254.34
Other Operating Expenses
109.73105.4687.16113.0587.7373.21
Operating Expenses
185.92166.82162.33198.28165.84147.31
Operating Income
317.15321.95273.75204.88180.96131.8
Interest Expense
-0.39---0.93-4.05-3.82
Interest & Investment Income
17.7617.7610.174.253.22.78
Currency Exchange Gain (Loss)
332.169.483.170.95
Other Non Operating Income (Expenses)
11.23---00.010.23
EBT Excluding Unusual Items
348.74342.71286.08217.68183.29131.94
Gain (Loss) on Sale of Assets
---0.110.260.27
Other Unusual Items
---2.62--
Pretax Income
348.74342.71286.08220.41183.55132.21
Income Tax Expense
89.6288.0472.5756.3847.2834.91
Net Income
259.13254.67213.51164.03136.2797.3
Net Income to Common
259.13254.67213.51164.03136.2797.3
Net Income Growth
11.49%19.28%30.16%20.37%40.05%14.14%
Shares Outstanding (Basic)
373737393940
Shares Outstanding (Diluted)
373737393940
Shares Change (YoY)
-0.20%--4.09%-0.91%-3.59%-0.01%
EPS (Basic)
6.986.865.754.243.492.40
EPS (Diluted)
6.986.865.754.243.492.40
EPS Growth
11.71%19.28%35.72%21.49%45.42%14.02%
Free Cash Flow
230.3275.9251.45112.552.2496.64
Free Cash Flow Per Share
6.217.441.392.911.342.39
Dividend Per Share
0.5000.5000.500---
Gross Margin
50.33%48.78%48.53%42.18%42.10%44.57%
Operating Margin
31.73%32.13%30.46%21.44%21.97%21.05%
Profit Margin
25.92%25.42%23.76%17.16%16.54%15.54%
Free Cash Flow Margin
23.04%27.54%5.73%11.77%6.34%15.43%
EBITDA
331.8334.65286.27218.21191.41141.72
EBITDA Margin
33.19%33.40%31.86%22.83%23.23%22.63%
D&A For EBITDA
14.6512.712.5113.3310.459.92
EBIT
317.15321.95273.75204.88180.96131.8
EBIT Margin
31.73%32.13%30.46%21.44%21.97%21.05%
Effective Tax Rate
25.70%25.69%25.37%25.58%25.76%26.41%
Revenue as Reported
1,0361,027914.4974.98833.4632.36
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.